335 related articles for article (PubMed ID: 24297161)
1. Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.
Dunbar EM; Coats BS; Shroads AL; Langaee T; Lew A; Forder JR; Shuster JJ; Wagner DA; Stacpoole PW
Invest New Drugs; 2014 Jun; 32(3):452-64. PubMed ID: 24297161
[TBL] [Abstract][Full Text] [Related]
2. Haplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in children.
Shroads AL; Coats BS; McDonough CW; Langaee T; Stacpoole PW
J Clin Pharmacol; 2015 Jan; 55(1):50-5. PubMed ID: 25079374
[TBL] [Abstract][Full Text] [Related]
3. Human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate.
Shroads AL; Langaee T; Coats BS; Kurtz TL; Bullock JR; Weithorn D; Gong Y; Wagner DA; Ostrov DA; Johnson JA; Stacpoole PW
J Clin Pharmacol; 2012 Jun; 52(6):837-49. PubMed ID: 21642471
[TBL] [Abstract][Full Text] [Related]
4. Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans.
Shroads AL; Coats BS; Langaee T; Shuster JJ; Stacpoole PW
Drug Metab Pers Ther; 2015 Mar; 30(1):49-55. PubMed ID: 25283137
[TBL] [Abstract][Full Text] [Related]
5. Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal.
Guo X; Dixit V; Liu H; Shroads AL; Henderson GN; James MO; Stacpoole PW
Drug Metab Dispos; 2006 Jan; 34(1):36-42. PubMed ID: 16199472
[TBL] [Abstract][Full Text] [Related]
6. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: dose-response relationships and age as a modifying factor.
Schultz IR; Merdink JL; Gonzalez-Leon A; Bull RJ
Toxicology; 2002 May; 173(3):229-47. PubMed ID: 11960676
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral dichloroacetate in dogs.
Maisenbacher HW; Shroads AL; Zhong G; Daigle AD; Abdelmalak MM; Samper IS; Mincey BD; James MO; Stacpoole PW
J Biochem Mol Toxicol; 2013 Dec; 27(12):522-5. PubMed ID: 24038869
[TBL] [Abstract][Full Text] [Related]
8. Exposure of Rats to Multiple Oral Doses of Dichloroacetate Results in Upregulation of Hepatic Glutathione Transferases and NAD(P)H Dehydrogenase [Quinone] 1.
Squirewell EJ; Mareus R; Horne LP; Stacpoole PW; James MO
Drug Metab Dispos; 2020 Nov; 48(11):1224-1230. PubMed ID: 32873592
[TBL] [Abstract][Full Text] [Related]
9. Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping Assay.
Langaee T; Wagner R; Horne LP; Lawson LA; Becker C; Shahin M; Starostik P; Stacpoole PW
Genet Test Mol Biomarkers; 2018 Apr; 22(4):266-269. PubMed ID: 29641284
[TBL] [Abstract][Full Text] [Related]
10.
Tian DD; Bennett SK; Coupland LA; Forwood K; Lwin Y; Pooryousef N; Tea I; Truong TT; Neeman T; Crispin P; D'Rozario J; Blackburn AC
Pharmacol Res Perspect; 2019 Dec; 7(6):e00526. PubMed ID: 31624634
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.
James MO; Jahn SC; Zhong G; Smeltz MG; Hu Z; Stacpoole PW
Pharmacol Ther; 2017 Feb; 170():166-180. PubMed ID: 27771434
[TBL] [Abstract][Full Text] [Related]
12. Effects of Multiple Doses of Dichloroacetate on GSTZ1 Expression and Activity in Liver and Extrahepatic Tissues of Young and Adult Rats.
Squirewell EJ; Smeltz MG; Rowland-Faux L; Horne LP; Stacpoole PW; James MO
Drug Metab Dispos; 2020 Nov; 48(11):1217-1223. PubMed ID: 32873593
[TBL] [Abstract][Full Text] [Related]
13. Prenatal and postnatal expression of glutathione transferase ΞΆ 1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetate.
Li W; Gu Y; James MO; Hines RN; Simpson P; Langaee T; Stacpoole PW
Drug Metab Dispos; 2012 Feb; 40(2):232-9. PubMed ID: 22028318
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent kinetics and metabolism of dichloroacetate: possible relevance to toxicity.
Shroads AL; Guo X; Dixit V; Liu HP; James MO; Stacpoole PW
J Pharmacol Exp Ther; 2008 Mar; 324(3):1163-71. PubMed ID: 18096758
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic considerations with dichloroacetate dosing.
James MO; Stacpoole PW
Pharmacogenomics; 2016 May; 17(7):743-53. PubMed ID: 27143230
[TBL] [Abstract][Full Text] [Related]
16. Clinical physiology and pharmacology of GSTZ1/MAAI.
Stacpoole PW
Biochem Pharmacol; 2023 Nov; 217():115818. PubMed ID: 37742772
[TBL] [Abstract][Full Text] [Related]
17. The influence of human GSTZ1 gene haplotype variations on GSTZ1 expression.
Langaee TY; Zhong G; Li W; Hamadeh I; Solayman MH; McDonough CW; Stacpoole PW; James MO
Pharmacogenet Genomics; 2015 May; 25(5):239-45. PubMed ID: 25738370
[TBL] [Abstract][Full Text] [Related]
18. Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.
Garon EB; Christofk HR; Hosmer W; Britten CD; Bahng A; Crabtree MJ; Hong CS; Kamranpour N; Pitts S; Kabbinavar F; Patel C; von Euw E; Black A; Michelakis ED; Dubinett SM; Slamon DJ
J Cancer Res Clin Oncol; 2014 Mar; 140(3):443-52. PubMed ID: 24442098
[TBL] [Abstract][Full Text] [Related]
19. The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?
Stacpoole PW
Environ Health Perspect; 2011 Feb; 119(2):155-8. PubMed ID: 20920954
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Glutathione Transferase Zeta 1 Is Inactivated More Rapidly by Dichloroacetate than the Cytosolic Enzyme in Adult and Juvenile Rat Liver.
Smeltz MG; Hu Z; Zhong G; Jahn SC; Rowland-Faux L; Horne LP; Stacpoole PW; James MO
Chem Res Toxicol; 2019 Oct; 32(10):2042-2052. PubMed ID: 31524376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
